New Oxford spinout company Kodiform Therapeutics launches to tackle cancer
Kodiform Therapeutics, a new joint spinout company from The Institute of Cancer Research, London, and the University of Oxford, has received a major seed funding investment from venture creation firm Oxford Science Enterprises.